Gilliland Jeter Wealth Management LLC Blueprint Medicines Corp Transaction History
Gilliland Jeter Wealth Management LLC
- $287 Billion
- Q1 2024
A detailed history of Gilliland Jeter Wealth Management LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Gilliland Jeter Wealth Management LLC holds 900 shares of BPMC stock, worth $99,324. This represents 0.03% of its overall portfolio holdings.
Number of Shares
900Holding current value
$99,324% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
313Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$712 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$696 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$690 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$461 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$276 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.59B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...